Page last updated: 2024-11-07

3-(2-hydroxy-4-(1,1-dimethylheptylphenyl)cyclohexan-1-ol)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

CP 47497: cannabimimetic agent; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID125835
CHEBI ID191114
SCHEMBL ID11166255
MeSH IDM0110155

Synonyms (30)

Synonym
cp 47497
2-[(1r,3s)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol
CHEBI:191114
70434-82-1
phenol, 5-(1,1-dimethylheptyl)-2-[(1r,3s)-3-hydroxycyclohexyl]-
rel-5-(1,1-dimethylheptyl)-2-[(1r,3s)-3-hydroxycyclohexyl]phenol
unii-fapqaukc04
dea no.7297
(+-)-cp 47497
cp47497
3-(2-hydroxy-4-(1,1-dimethylheptylphenyl)cyclohexan-1-ol)
fapqaukc04 ,
cis-3-(2-hydroxy-4-(1,1-dimethylheptylphenyl)-cyclohexan-1-ol)
cp47,497
3-(4-(1,1-dimethylheptyl)-2-hydroxyphenyl)cyclohexanol
hsdb 8001
CCG-208720
5-(1,1-dimethylheptyl)-2-[(1r,3s)-3-hydroxycyclohexyl]phenol
ZWWRREXSUJTKNN-AEFFLSMTSA-N ,
cis-3-[4-(1,1-dimethylheptyl) 2-hydroxyphenyl]cyclohexanol
cis-3-[4-(1,1-dimethylheptyl)-2-hydroxyphenyl]cyclohexanol
SCHEMBL11166255
J-520105
AKOS027324391
(cis)-3-[4-(1,1-dimethylheptyl)-2-hydroxyphenyl]cyclohexanol
2-((1r,3s)-3-hydroxycyclohexyl)-5-(2-methyloctan-2-yl)phenol
J-505191
(+)-cp 47,497
DTXSID401009968
DTXSID201017793

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"A cumulative dosing THC discrimination procedure was utilized to evaluate sex differences in the discriminative stimulus effects of THC and three synthetic cannabinoids: CP47,497, WIN55,212-2, and JWH-018."( Comparison of the discriminative stimulus and response rate effects of
Craft, RM; Lefever, TW; Marusich, JA; Wiley, JL, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
ring assemblyTwo or more cyclic systems (single rings or fused systems) which are directly joined to each other by double or single bonds are named ring assemblies when the number of such direct ring junctions is one less than the number of cyclic systems involved.
alkylbenzeneA monocyclic arene that is benzene substituted with one or more alkyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (11.11)18.7374
1990's3 (16.67)18.2507
2000's2 (11.11)29.6817
2010's11 (61.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.03 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]